Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SangStat Will Launch Website To Boost Transplant Pharmacy Enrollment

Executive Summary

SangStat will set up a "transplantrx.com" website designed to increase enrollment in The Transplant Pharmacy, the company's mail-order pharmacy and patient disease management program.

You may also be interested in...



Eon's Cyclosporine Capsules Receive Approval As First-Time Neoral Generic

FDA's generic drugs office opened 2000 with the Jan. 13 approval of Eon Labs' cyclosporine softgel capsules as the first generic of Novartis' Neoral capsules, which comprise 96% of the cyclosporine market.

Eon's Cyclosporine Capsules Receive Approval As First-Time Neoral Generic

FDA's generic drugs office opened 2000 with the Jan. 13 approval of Eon Labs' cyclosporine softgel capsules as the first generic of Novartis' Neoral capsules, which comprise 96% of the cyclosporine market.

WLF Appeal Could Receive Hearing By Spring 2000 Under FDA Expedited Plan

The Washington Legal Foundation will challenge FDA's request for an expedited appeal to D.C. District Court Judge Royce Lamberth's July 28 ruling invalidating the off-label dissemination provisions of the FDA Modernization Act, WLF Chief Counsel Richard Samp told a Food & Drug Law Institute conference in Bethesda, Md. Sept. 13.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel